Robert I. Tepper is 10% Owner at Relay Therapeutics, Inc. (RLAY). They have made 18 open-market trades across 11 companies since 2006, most recently 2023-01-27.
CIK 0001192595
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $7.0M since 2017, against 16 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 43% | 36% |
| Avg Move | -6.5% | +0.4% | +6.1% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYGR | SELL | 2023-01-27 | 2023-01-31 | $9.02 | $451K | -18.5% | -23.7% | -23.5% |
| RVMD | SELL | 2022-06-08 | 2022-06-10 | $20.25 | $17.0M | +12.8% | +29.3% | +27.7% |
| RVMD | SELL | 2021-06-03 | 2021-06-07 | $30.21 | $32.8M | +6.7% | -2.8% | -3.5% |
| RLAY | SELL | 2021-01-12 | 2021-01-14 | $40.31 | $312.2M | +26.5% | +0.9% | -22.4% |
| JNCE | SELL | 2020-11-19 | 2020-11-23 | $7.01 | $105K | +1.8% | -3.2% | +62.9% |
| CNST | BUY | 2018-07-23 | 2018-07-24 | $15.00 | $4.0M | -9.7% | -11.7% | -40.6% |
| ALNA | BUY | 2017-11-06 | 2017-11-06 | $14.00 | $3.0M | +15.4% | +37.3% | -22.2% |
| CTMX | SELL | 2017-10-04 | 2017-10-04 | $24.34 | $1.2M | -9.8% | -11.0% | -4.2% |
| CTMX | SELL | 2017-09-19 | 2017-09-21 | $18.00 | $360K | +8.4% | +14.4% | +26.1% |
| CTMX | SELL | 2017-06-29 | 2017-06-30 | $16.00 | $240K | +3.6% | -12.8% | +16.8% |
| GBT | SELL | 2017-04-06 | 2017-04-10 | $33.23 | $2.1M | -9.9% | -6.1% | -12.4% |
| BPMC | SELL | 2017-02-07 | 2017-02-09 | $35.28 | $35.3M | -6.1% | +16.5% | +14.4% |
| BLUE | SELL | 2014-09-11 | 2014-09-12 | $36.54 | $4.6M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL | 2014-01-21 | 2014-01-23 | $23.91 | $6.0M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL | 2014-01-15 | 2014-01-17 | $22.43 | $6.9M | -26.5% | +1.0% | +1.0% |
| BLUE | SELL | 2014-01-10 | 2014-01-14 | $21.90 | $7.4M | -26.5% | +1.0% | +1.0% |
| MLNM | SELL · 10b5-1 | 2007-02-12 | 2007-02-13 | $11.36 | $256K | N/A | N/A | N/A |
| MLNM | SELL | 2006-11-20 | 2006-11-20 | $11.50 | $172K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2006-10-30 | 2006-10-31 | $11.87 | $712K | N/A | N/A | N/A |
| MLNM | SELL | 2006-08-09 | 2006-08-10 | $9.87 | $17K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| EBIO | 4,207,120 | $13.8M |
| VYGR | 5,073,933 | $9.6M |
| ZFGN | 479,081 | $5.7M |
| BLUE | 89,017 | $442K |
| KALA | 1,621,092 | $304K |
| ALNA | 2,575,964 | $193K |
| CTMX | 29,516 | $67K |
| MLNM | 105,137 | — |
| Total | $2.3B |
Shares reported on the most recent Form 4, priced at the 2023-01-31 close. 1 holding could not be priced and is excluded from the total.